Latest News & Features

Reset all filters
Channels & Sectors
Geography
Company

Refine Search
Patents
The patent landscape for biologics, biosimilars, and advanced therapeutic antibodies is undergoing rapid change, presenting both opportunities and challenges for innovators and manufacturers. This panel will explore current issues and strategies in this dynamic field.   29 October 2024
Patents
Korean pharmaceutical, biotech, and life sciences companies are actively expanding globally, leading to more complex and multifaceted IP strategies than in the past.   29 October 2024
Patents
Join us as we delve into the complexities of international harmonization and global patent strategies in the ever-evolving landscape of IP rights.   29 October 2024
Patents
How to foster effective collaboration between academia and industry? Best practices for bridging that gap between the two spheres Technology transfer How to leverage academic research for commercialization   29 October 2024
Patents
The integration of cutting-edge medical technology within the life sciences has ushered in an era of unprecedented innovation, transforming the landscape of healthcare and patient wellbeing.   29 October 2024
Patents
On January 10 this year, the director of the USPTO issued new guidelines on enablement under 35 U.S.C §112. In recent years, the landscape of patent law in the United States has undergone a significant shift, with courts adopting a more stringent stance on the criteria of enablement and written description.   29 October 2024
Patents
In this session, Will James and Tim Harris will discuss their personal experiences litigating life sciences cases before the UPC. They will share their substantive and procedural insights, as well as strategic considerations and pitfalls to avoid.   29 October 2024
Patents
Long-recognised, unwritten jurisdictional norms have seen questions of validity and infringement of registered IP rights reserved to the courts of the country of registration.   29 October 2024
Patents
Patents are key to ensuring continued investment in pharma R&D. What are the unique patent considerations for pharma/biotech patents and AI patents in Europe?   29 October 2024
Patents
In the world of intellectual property, securing patents for innovative ideas rests heavily on the criteria of novelty, non-obviousness, and the inventive step.   29 October 2024

Not finding what you're looking for, please try resetting your applied search and filters,
or try the
full site search.